4''-trans-Hydroxy cilostazol
CAS : 87153-04-6
Ref. 3D-FH23951
| 1mg | Arrêté | ||
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté |
Informations sur le produit
Nom :
4''-trans-Hydroxy cilostazol
Synonymes :
- trans-3,4-Dihydro-6-[4-[1-(4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinoneOPC 13213
Description :
Cilostazol is a drug that belongs to the class of antiplatelet agents and is prescribed for the prevention of thrombotic events. Cilostazol has been shown to inhibit platelet aggregation by blocking adenosine diphosphate (ADP) receptors on the platelets. It also inhibits p38, an enzyme involved in apoptosis. This drug has shown to be effective in reducing atherosclerosis and preventing cardiovascular disease, but carries the risk of adverse effects such as gastrointestinal bleeding. The drug is absorbed orally, but can be reconstituted with water if taken with food or milk. Cilostazol has been shown to have a pharmacokinetic profile similar to cilostamide, which is another anti-platelet agent.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
385.46 g/mol
Formule :
C20H27N5O3
Degré de pureté :
Min. 95%
InChI :
InChI=1S/C20H27N5O3/c26-16-7-5-15(6-8-16)25-19(22-23-24-25)3-1-2-12-28-17-9-10-18-14(13-17)4-11-20(27)21-18/h9-10,13,15-16,26H,1-8,11-12H2,(H,21,27)
Code InChI :
InChIKey=KFXNZXLUGHLDBB-UHFFFAOYSA-N
SMILES :
O=C1CCc2cc(OCCCCc3nnnn3C3CCC(O)CC3)ccc2N1
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
